Literature DB >> 22415077

Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.

Christian Langelueddecke1, Martin Jakab, Nina Ketterl, Lukas Lehner, Clemens Hufnagl, Sabine Schmidt, John P Geibel, Johannes Fuerst, Markus Ritter.   

Abstract

BACKGROUND/AIMS: The function of β-cells is regulated by nutrient uptake and metabolism. The cells' metabolic state can be expressed as concentration ratios of AMP, ADP and ATP. Relative changes in these ratios regulate insulin release. An increase in the intracellular ATP concentration causes closure of K(ATP) channels and cell membrane depolarization, which triggers stimulus-secretion coupling (SSC). In addition to K(ATP) channels, the AMP-dependent protein kinase (AMPK), a major cellular fuel sensor in a variety of cells and tissues, also affects insulin secretion and β-cell survival. In a previous study we found that the widely used AMPK inhibitor compound C retards proliferation and induces apoptosis in the rat β-cell line INS-1E. We therefore tested the effects of AMPK activators (AICAR and metformin), and compound C on AMPK phosphorylation, insulin secretion, K(ATP) channel currents, cell membrane potential, intracellular calcium concentration, apoptosis and cell cycle distribution of INS-1E cells under standard cell culture conditions (11 mM glucose).
METHODS: Western blotting, ELISA, patch-clamp, calcium imaging and flow cytometry.
RESULTS: We found that basal AMPK phosphorylation is enhanced by AICAR (1 mM) and metformin (1 mM) but remained unaffected by compound C (10 μM). Both AICAR and compound C stimulated basal insulin secretion whereas metformin had no effect. Pre-incubation with AICAR (1 mM) caused an inhibition of K(ATP) currents but did not significantly alter the average cell membrane potential (Vm) or the threshold potential of electrical activity. Acute administration of AICAR (300 μM) led to a depolarization of Vm, which was not due to an inhibition of the basal- or glucose-induced chloride conductance, and was not accompanied by elevations of intracellular calcium (Ca(i)). AICAR had no additive blocking effect on K(ATP) currents when applied together with tolbutamide. Compound C applied over 24 hours induced an increase in the percentage of cells positive for caspase activity, whereas AICAR (1 mM) applied for 48 hours was without effect. Medium glucose concentration <3 mM caused cell cycle arrest, caspase activation and an increase of cell granularity.
CONCLUSION: We conclude that under standard cell culture conditions the AMPK modulators AICAR and compound C, but not metformin, stimulate insulin secretion by AMPK-independent mechanisms.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22415077     DOI: 10.1159/000337589

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  12 in total

1.  Reduced AMPKα2 protein expression restores glucose-induced insulin secretion in islets from calorie-restricted rats.

Authors:  Maria Esméria C Amaral; Rosane A Ribeiro; Emerielle C Vanzela; Helena C Barbosa-Sampaio
Journal:  Int J Exp Pathol       Date:  2016-01-19       Impact factor: 1.925

2.  Ginsenoside Rb3 strengthens the hypoglycemic effect through AMPK for inhibition of hepatic gluconeogenesis.

Authors:  Fanli Meng; Xiaotian Su; Wei Li; Yinan Zheng
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

3.  AMP-activated protein kinase regulates hERG potassium channel.

Authors:  Ahmad Almilaji; Carlos Munoz; Bernat Elvira; Abul Fajol; Tatsiana Pakladok; Sabina Honisch; Ekaterina Shumilina; Florian Lang; Michael Föller
Journal:  Pflugers Arch       Date:  2013-05-29       Impact factor: 3.657

4.  AMP-activated protein kinase as regulator of P2Y(6) receptor-induced insulin secretion in mouse pancreatic β-cells.

Authors:  Ramachandran Balasubramanian; Hiroshi Maruoka; P Suresh Jayasekara; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2013-01-17       Impact factor: 5.858

5.  AMP kinase regulates K-ATP currents evoked by NMDA receptor stimulation in rat subthalamic nucleus neurons.

Authors:  K-Z Shen; V Yakhnitsa; A C Munhall; S W Johnson
Journal:  Neuroscience       Date:  2014-05-27       Impact factor: 3.590

6.  Association of bone morphogenetic protein 6 with exocrine gland dysfunction in patients with Sjögren's syndrome and in mice.

Authors:  Hongen Yin; Javier Cabrera-Perez; Zhenan Lai; Drew Michael; Melodie Weller; William D Swaim; Xibao Liu; Marcelo A Catalán; Eduardo M Rocha; Nevien Ismail; Sandra Afione; Noreen A Rana; Giovanni Di Pasquale; Ilias Alevizos; Indu Ambudkar; Gabor G Illei; John A Chiorini
Journal:  Arthritis Rheum       Date:  2013-12

7.  A Novel Phenylchromane Derivative Increases the Rate of Glucose Uptake in L6 Myotubes and Augments Insulin Secretion from Pancreatic Beta-Cells by Activating AMPK.

Authors:  Naomi Rozentul; Yosef Avrahami; Moran Shubely; Laura Levy; Anna Munder; Guy Cohen; Erol Cerasi; Shlomo Sasson; Arie Gruzman
Journal:  Pharm Res       Date:  2017-10-05       Impact factor: 4.200

8.  OM2, a Novel Oligomannuronate-Chromium(III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1α Pathway.

Authors:  Jiejie Hao; Cui Hao; Lijuan Zhang; Xin Liu; Xiaolin Zhou; Yunlou Dun; Haihua Li; Guangsheng Li; Xiaoliang Zhao; Yuanyuan An; Jiankang Liu; Guangli Yu
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

9.  Implication of transcriptional repression in compound C-induced apoptosis in cancer cells.

Authors:  R Y Dai; X F Zhao; J J Li; R Chen; Z L Luo; L X Yu; S K Chen; C Y Zhang; C Y Duan; Y P Liu; C H Feng; X M Xia; H Li; J Fu; H Y Wang
Journal:  Cell Death Dis       Date:  2013-10-24       Impact factor: 8.469

10.  AMPK inhibition blocks ROS-NFκB signaling and attenuates endotoxemia-induced liver injury.

Authors:  Yuan Guo; Yi Zhang; Kai Hong; Fengyan Luo; Qiuping Gu; Nonghua Lu; Aiping Bai
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.